Vicinity Centres (ASX:VCX)
Australia · Delayed Price · Currency is AUD 2.440
-0.030 (-1.21%)
Aug 1, 2025, 4:10 PM AEST
Verve Therapeutics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
Rental Revenue | 1,262 | 1,249 | 1,210 | 1,123 | 1,119 | 1,152 | Upgrade |
Property Management Fees | 59.7 | 67.8 | 64.8 | 56.6 | 48.8 | 60.8 | Upgrade |
Other Revenue | 39.6 | -14.3 | -50.9 | 15.9 | -34.2 | -124.1 | Upgrade |
| 1,372 | 1,312 | 1,231 | 1,198 | 1,135 | 1,092 | Upgrade | |
Revenue Growth (YoY | 10.25% | 6.62% | 2.69% | 5.58% | 3.92% | -16.34% | Upgrade |
Property Expenses | 423.2 | 395.5 | 349.7 | 348 | 299 | 315.2 | Upgrade |
Selling, General & Administrative | 7.6 | 7.6 | 7.3 | 6.1 | 4 | 3.7 | Upgrade |
Depreciation & Amortization | 4.4 | 4.5 | 4.9 | 5.5 | 6.1 | 6.1 | Upgrade |
Other Operating Expenses | 147.6 | 148.2 | 149.9 | 141.4 | 134.3 | 99.2 | Upgrade |
Total Operating Expenses | 582.6 | 555.6 | 490.3 | 514.7 | 531.4 | 592.7 | Upgrade |
Operating Income | 789.5 | 756.4 | 740.2 | 683.6 | 603.6 | 499.5 | Upgrade |
Interest Expense | -227.6 | -218 | -206 | -188.9 | -168.9 | -195.2 | Upgrade |
Currency Exchange Gain (Loss) | -160 | 6.9 | -139.9 | -10.3 | 77.5 | -13.1 | Upgrade |
Other Non-Operating Income | 186.1 | 37.8 | 67.7 | 89.9 | -116.6 | 64.8 | Upgrade |
EBT Excluding Unusual Items | 588 | 583.1 | 462 | 574.3 | 395.6 | 356 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -427 | Upgrade |
Asset Writedown | 225.5 | -38.9 | -195.9 | 633.3 | -642.7 | -1,718 | Upgrade |
Pretax Income | 813.5 | 544.2 | 266.1 | 1,208 | -247.1 | -1,789 | Upgrade |
Income Tax Expense | -2.7 | -2.9 | -5.4 | -7.6 | 10.9 | 12.1 | Upgrade |
Net Income | 816.2 | 547.1 | 271.5 | 1,215 | -258 | -1,801 | Upgrade |
Net Income to Common | 816.2 | 547.1 | 271.5 | 1,215 | -258 | -1,801 | Upgrade |
Net Income Growth | 156.10% | 101.51% | -77.66% | - | - | - | Upgrade |
Basic Shares Outstanding | 4,552 | 4,552 | 4,552 | 4,552 | 4,552 | 3,808 | Upgrade |
Diluted Shares Outstanding | 4,564 | 4,563 | 4,561 | 4,561 | 4,560 | 3,815 | Upgrade |
Shares Change (YoY) | 0.07% | 0.04% | -0.01% | 0.03% | 19.52% | -0.58% | Upgrade |
EPS (Basic) | 0.18 | 0.12 | 0.06 | 0.27 | -0.06 | -0.47 | Upgrade |
EPS (Diluted) | 0.18 | 0.12 | 0.06 | 0.27 | -0.06 | -0.47 | Upgrade |
EPS Growth | 155.78% | 101.51% | -77.66% | - | - | - | Upgrade |
Dividend Per Share | 0.118 | 0.117 | 0.120 | 0.104 | 0.100 | 0.077 | Upgrade |
Dividend Growth | -2.07% | -2.08% | 15.38% | 4.00% | 29.87% | -51.57% | Upgrade |
Operating Margin | 57.54% | 57.65% | 60.15% | 57.05% | 53.18% | 45.73% | Upgrade |
Profit Margin | 59.48% | 41.70% | 22.06% | 101.41% | -22.73% | -164.90% | Upgrade |
EBITDA | 793.9 | 760.9 | 745.1 | 689.1 | 609.7 | 503.2 | Upgrade |
EBITDA Margin | 57.86% | 57.99% | 60.55% | 57.51% | 53.72% | 46.07% | Upgrade |
D&A For Ebitda | 4.4 | 4.5 | 4.9 | 5.5 | 6.1 | 3.7 | Upgrade |
EBIT | 789.5 | 756.4 | 740.2 | 683.6 | 603.6 | 499.5 | Upgrade |
EBIT Margin | 57.54% | 57.65% | 60.15% | 57.05% | 53.18% | 45.73% | Upgrade |
Funds From Operations (FFO) | 663.1 | 664.6 | 684.8 | 598.3 | 558.8 | 520.3 | Upgrade |
Adjusted Funds From Operations (AFFO) | - | 561.9 | 576 | 496.8 | 485.7 | 417.5 | Upgrade |
FFO Payout Ratio | 80.67% | 82.88% | 76.12% | 85.96% | 27.70% | 113.24% | Upgrade |
Revenue as Reported | 1,333 | 1,326 | 1,281 | 1,182 | 1,169 | 1,216 | Upgrade |
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.